{
    "2021-01-29": [
        [
            {
                "time": "",
                "original_text": "东莞证券----医药生物行业2020年疫苗批签发总结：热门大品种持续放量关注自研能力强的疫苗龙头【行业研究】",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "热门大品种",
                        "自研能力",
                        "疫苗龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "13价肺炎疫苗实际销量减少178万支，净利润同比却增6倍，沃森生物如何做到的",
                "features": {
                    "keywords": [
                        "13价肺炎疫苗",
                        "销量减少",
                        "净利润增长",
                        "沃森生物"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "百克生物2019营收9.8亿销售费4.5亿 代理商涉5起行贿 其他违规处罚",
                "features": {
                    "keywords": [
                        "百克生物",
                        "营收",
                        "销售费用",
                        "代理商",
                        "行贿",
                        "违规处罚"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物近七成公司年报预喜 机构看好行业长期投资价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报预喜",
                        "长期投资价值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}